Latest News

Each spring the Graduate School of Arts and Sciences recognizes professors from each of four divisions who provide “superb teaching, advising, and mentoring” to Yale students. 

Addressing serious side effects that can derail immunotherapy cancer treatments is the focus of research work at the Yale Cancer Center as well as clinical programs at Smilow Cancer Hospitals.

C2S-Scale looks deep into how to best represent cells and biological information as text, opening up exciting applications for language-driven single-cell analysis with large language models.

The Kavli Institute for Neuroscience is pleased to announce the recipients of the 2025 Kavli Postdoctoral Fellowship.

Scientists at Yale School of Medicine think so, and an initiative funded by the Carol and Gene Ludwig Family Foundation is supporting efforts to find out more about how inflammation and immune responses contribute to neurodegenerative diseases.

A Yale lab links skin inflammation to the development of food allergies via a skin-gut connection, suggesting clues to a little-understood immune reaction.

A novel decentralized clinical trial found that Paxlovid was ineffective in alleviating Long COVID symptoms but underscored the importance of a patient-centered approach.

Akiko Iwasaki, PhD, Sterling Professor of Immunobiology and Professor of Dermatology and of Molecular, Cellular, and Developmental Biology and of Epidemiology (Microbial Diseases), has devoted her career to studying vaccines, to ward off infectious diseases. In this video, Dr. Iwasaki shares insight about breakthroughs in understanding Long COVID, and the importance of diverse voices in science.

The American Association for the Advancement of Science has elected eight Yale faculty members as part of its latest class of fellows.